Browse All

Current Filters

CLEAR FILTER x

TITLE

Predictors of Achievement of Response With Cenobamate: Post-hoc Subset Analysis From a Phase 3, Open-Label Safety Study

Author:Wechsler, MD, PhD, Robert   Vossler, MD, David G.   Kerr, MD, PhD, Wesley T.   Stern, MS, Sean   Wade, MBA, Clarence T.   Rosenfeld, MD, William E.   

Session Name:S44: Epilepsy/Clinical Neurophysiology (EEG): Epilepsy Outcomes  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:S44.006  

Author Institution:Consultants in Epilepsy & Neurology and Idaho Comprehensive Epilepsy Center, Boise, ID, USA, Boise, ID  University of Washington School of Medicine, Seattle, WA, USA, Renton, WA  Department of Neurology, University of Michigan, Ann Arbor, MI, USA, Ann Arbor, MI  SK Life Science, Inc., Paramus, NJ, USA, Paramus, NJ  Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, MO, USA, St. Louis, MO  

Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients

Author:O'Dwyer, MD, Rebecca   Stern, MS, Sean   Wade, MBA, Clarence   Guggilam, PhD, Anuradha   Rosenfeld, MD, William E.   

Session Name:P4: Epilepsy/Clinical Neurophysiology (EEG): Real-World Use of ASMs  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P4.002  

Author Institution:Epilepsy Section, Department of Neurological Sciences, Rush University Medical Center, Chicago, USA, Chicago, IL  SK Life Science, Inc., Paramus, NJ, USA, Paramus, NJ  Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, MO, USA, St. Louis, MO  

Concomitant Drug Load Reduction During Adjunctive Cenobamate Therapy: Post-hoc Analysis of a Phase 3, Open-Label Study

Author:Aboumatar, MD, Sami   Ferrari, RPh, MBA, Louis   Stern, MS, Sean   Wade, MBA, Clarence   Weingarten, PharmD, Mindl   Connor, MD, Gregory S.   Rosenfeld, MD, William E.   

Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P11.006  

Author Institution:Austin Epilepsy Care Center, Austin, TX, USA, Austin, TX  SK Life Science, Inc., Paramus, NJ, USA, Paramus, NJ  Neurological Center of Oklahoma, Tulsa, OK, USA, Tulsa, OK  Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, MO, USA, St. Louis, MO  

Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study

Author:Stern, MS, Sean   Wechsler, MD, PhD, Robert   Kerr, MD, PhD, Wesley T.   Wade, MBA, Clarence T.   Vossler, MD, David G.   Rosenfeld, MD, William E.   

Session Name:P14: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 2  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P14.005  

Author Institution:SK Life Science, Inc., Paramus, NJ, USA, Paramus, NJ  Consultants in Epilepsy & Neurology and Idaho Comprehensive Epilepsy Center, Boise, ID, USA, Boise, ID  Department of Neurology, University of Michigan, Ann Arbor, MI, USA, Ann Arbor, MI  University of Washington School of Medicine, Seattle, WA, USA, Renton, WA  Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, MO, USA, St. Louis, MO